Quantifying Conflict of Interest in the Choice of Anti-VEGF Agents
David J Browning,1 Paul B Greenberg2 1Charlotte, Eye, Ear, Nose, and Throat Associates, Charlotte, NC, 28210, USA; 2Division of Ophthalmology, Alpert Medical School, Brown University, Providence, RI, USACorrespondence: David J Browning Email djbrowning179@gmail.comPurpose: To quantify the economic i...
Guardado en:
Autores principales: | Browning DJ, Greenberg PB |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c5e2e22f25dd4e10947d431574c45d58 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Response of eyes with age-related macular degeneration to anti-VEGF drugs and implications for therapy planning
por: Miyamoto N, et al.
Publicado: (2017) -
Gifts and Conflicts of Interest: In Shades of Gray?
por: Pasmanik Volochinsky,Diana, et al.
Publicado: (2018) -
FINANCIAL AND NON-FINANCIAL CONFLICTS OF INTERESTS IN PSYCHIATRY
por: Maj,Mario
Publicado: (2009) -
Investigation and Evaluation of Chinese Clinical Practice Guidelines Published in Medical Journals in 2019:Funding and Conflicts of Interest
por: SHI Qianling, et al.
Publicado: (2021) -
Anti-VEGF Therapy in Refractory Pituitary Adenomas and Pituitary Carcinomas: A Review
por: Congxin Dai, et al.
Publicado: (2021)